Product Overview & Details for Continuing Education Company 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025 Videos + Slides
General Information
Continuing Education Company provides primary care clinicians continuing medical education (CME) designed to improve patient outcomes by enhancing your knowledge, competence, and performance through evidence-based in-person conferences
Release date April 2025
runtime around 20 HOurs
Overview
This CME activity is comprised of recordings from the 10th Annual Diabetes, Obesity, and Metabolic Disease Conference that took place at the Westin San Diego Gaslamp Quarter in San Diego, California on April 25-27, 2025. This CME is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. The CME conference will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice.
Cardiometabolic disorders are a cluster of health conditions associated with cardiovascular disease and type 2 diabetes. It is estimated that over 1/3 of Americans suffer from a cardiometabolic disorder. The associated morbidity and mortality deserve increased clinical attention as we address risk factors predisposing individuals to these disorders. This program will help identify these conditions and their related complications to enable clinicians to appropriately intervene with evidence-based treatments and risk-factor control while improving patient education.
This course features sessions designed to update primary care clinicians involved in the treatment of patients at risk of cardiometabolic disorders. Topics include: Treating Obesity to Treat Diabetes, The Cardiovascular-Kidney-Metabolic Syndrome, 2025 ADA Standards of Care, Identifying and Treating HFpEF, Cases in Diabetes, Renal and Cardio-Kidney Metabolic Disease, The Biology of Obesity, Harnessing Anti-Obesity Medications, Midlife Metamorphosis in Women, Strategies for Optimizing Outcomes of Obesity Treatment, Cases in Obesity Management, Diagnosis and Management of MASLD/MASH, Secondary Causes of Hypertension, Treatment of LDL-C/Non-HDL-C/Apo B-Statins, Triglycerides and Lp(a), and Cases in Hypertension and Dyslipidemia.
Key Features
- Engaging content from renowned experts
- Personalized learning experience – learn at your own pace, on your own schedule, and in your preferred environment
- 16 HD-quality video-based lectures and presentation handouts
- CME365™ – Accessible anywhere, anytime – stream online for viewing at your leisure
- 15.25 CME/CE credits for physicians, nurses, and PAs, and ABIM MOC
Course Content
| On Demand Replay: FRIDAY, April 25, 2025 DAY 1 – Diabetes and Cardio-Renal Disease Management with Cases |
|
| M. McDonnell, MD | Treating Obesity to Treat Diabetes: Cutting the Gordian Knot |
| N. Desai, MD | The Cardiovascular-Kidney-Metabolic Syndrome: Timely Identification, Optimal Management, and Lingering Questions |
| M. McDonnell, MD | Highlights from the 2025 ADA Standards of Care: Drug Selection, Technology and Nutrition |
| N. Desai, MD | Identifying and Treating HFpEF: It’s All About the Phenotype… |
| M. McDonnell, MD & N. Desai, MD | Cases in Diabetes, Renal and Cardio-Kidney Metabolic Disease |
| On Demand Replay: SATURDAY, April 26, 2025 DAY 2 – Comprehensive Obesity Management and MASLD/MASH with Case Studies |
|
| L. Kaplan, MD | The Biology of Obesity and its Implications for Effective Treatment |
| D. Thiara, MD | Beyond the Scale: Harnessing Anti-Obesity Medications to Treat Obesity and its Complications |
| D. Thiara, MD | Midlife Metamorphosis in Women: Tackling Obesity During Aging and Menopause |
| L. Kaplan, MD | Strategies for Optimizing Outcomes of Obesity Treatment |
| L. Kaplan, MD & D. Thiara, MD | Cases in Obesity Management |
| M. Rinella, MD | Diagnosis and Management of MASLD/MASH |
| M. Rinella, MD | Cases in the Diagnosis and Management of MASLD/MASH |
| On Demand Replay: SUNDAY, April 27, 2025 DAY 3 – Hypertension and Dyslipidemia Management with Case Studies |
|
| J. Basile, MD (Chairperson) | Update on Secondary Causes of Hypertension |
| C. Ballantyne, MD | Treatment of LDL-C, Non-HDL-C and Apo B-Statins and Beyond |
| C. Ballantyne, MD | Triglycerides and Lp(a): Where Are We Now and Where Are We Going? |
| J. Basile, MD & C. Ballantyne, MD | Cases in Hypertension and Dyslipidemia |
Course Objectives
As a result of this educational activity, participants should be better able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Target Audience
This activity is designed for physicians, nurse practitioners, physician assistants, and other healthcare professionals specializing in primary care and family medicine.
